Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Miromatrix Medical: Q2 Earnings Insights

  Miromatrix Medical (NASDAQ:MIRO) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Miromatrix Medical (NASDAQ:MIRO) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Miromatrix Medical missed estimated earnings by 21.21%, reporting an EPS of $-0.4 versus an estimate of $-0.33.

Revenue was down $5 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 2.07% increase in the share price the next day.

 

To track all earnings releases for Miromatrix Medical visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Luna Innovations Announces Restatement Of Financial Statements; Says ” Determined That Its Financial Statements For The Fiscal Year Ended Dec 31, 2022, Interim Periods Ended Mar 31, 2022, Jun 30, 2022, Sep 30, 2022 And Mar 31, 2023, Cannot Be Relied Up…

By Benzinga Newsdesk
April 19, 8:32 AM
Luna Innovations Incorporated (NASDAQ:LUNA) (the "Company"), a global leader in advanced fiber optic-based technology, today announced that its Audit Committee of the Board of Directors (the "Audit Committee"), after

LUNA